RAT & FES Effects on Upper Limb Motor Function in Subacute Stroke Patients

Status Not yet recruiting

Clinical Trial Summary

Stroke is one of the leading causes of mortality worldwide and is the leading cause of disability. Currently, a large number of novel treatments are emerging with the aim of recovering the highest functionality and quality of life for these patients, including Robot Assisted Therapy (RAT) and functional electrostimulation (FES). The aim of this study is to observe the effect of FES with respect to conventional treatment and RAT for the improvement of motor function of the upper limb. For this purpose, a clinical trial will be carried out in which participants will be divided into two groups, a first group that will receive conventional treatment together with RAT and FES and a second group that will only receive conventional treatment combined with RAT. The hypothesis of the research group is that the group receiving conventional treatment together with RAT and FES will obtain greater improvements in motor function.

Clinical Trial Description

On the first day, participants will be asked to sign the informed consent form and the inclusion and exclusion criteria will be reconfirmed. Subsequently, manual grip strength, terminal opposition grip strength, subterminal opposition grip strength, subterminal opposition grip strength, subterminal-lateral grip strength and tridigital grip strength will be assessed using a JAMAR dynamometer. After this, the CAVIDACE quality of life scale and the FIM-FAM functional independence scale will be completed. Finally, motor function assessment will be carried out with the ARAT. After the end of the treatment, the reassessment will be carried out and the initial assessments will be repeated. Subsequently, study participants will be followed up telematically, assessing quality of life using the CAVIDACE scale. Follow-up will be carried out 3 and 6 months after the end of treatment. The data collected will be stored in a database created for this purpose with the Microsoft Access programme. Subsequently, they will be analysed using the SPSS/PC statistical programme. An exploratory analysis of all the information collected will be carried out for descriptive purposes; qualitative variables will be analysed using percentages, while quantitative variables will be analysed using mean and standard deviation. In both cases, the confidence intervals will be 95%. After verifying whether the distribution of the data is normal or not, the hypothesis tests indicated in each case will be applied (χ2, Student's t, ANOVA, etc.). A significance level of 0.05 will be used for hypothesis testing. All analyses will be performed on an intention-to-treat basis. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05570838
Study type	Interventional
Source	Neuron, Spain
Contact	Lerín Calvo
Phone	620187457
Email	alfre_lerin@hotmail.com
Status	Not yet recruiting
Phase	N/A
Start date	May 1, 2024
Completion date	July 1, 2025

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02208466` - Effects rTMS Combined With Fluoxetine on Motor Recovery in Stroke Patients	Phase 2
Completed	`NCT03193268` - Effects of Intensity-matched Agility and Cycling Exercise Training on PD Patients' Clinical Symptoms, Posture, and Mobility	N/A
Recruiting	`NCT05196178` - Spinal Cord Stimulation Therapy for Hereditary Spastic Paraplegias Patients	N/A
Completed	`NCT03168386` - Effect of Intensive Motor Rehabilitation in Subacute Stroke Patient	N/A
Recruiting	`NCT04742439` - Individualizing tDCS Dose	N/A
Completed	`NCT01574989` - Effects of rTMS and tDCS on Motor Function in Stroke	N/A
Recruiting	`NCT04373564` - Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years	Phase 4
Completed	`NCT06275633` - Behavioural Profiling of Disease-related Cognitive and Motor Impairment in PD	N/A
Recruiting	`NCT06465251` - Effects of Home-based CIMT and Clinic-based CIM on Stroke	N/A
Completed	`NCT01496885` - Observational Study to Evaluate the Simplified-STroke REhabilitation Assessment of Movement (S-STREAM) Scale in Subjects Who Have Experienced a Nonhemorrhagic Ischemic Stroke
Completed	`NCT05492097` - The Effect of Robot-assisted Walking Training on Hemiplegic Individuals	N/A
Not yet recruiting	`NCT04646577` - The Effect of tDCS Combined With Functional Task Training on Motor Recovery in Stroke Patients	N/A
Completed	`NCT03627364` - Analisys of Cortical Excitability and Motor Function of Post Stroke Patients

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

RAT and FES Effects on Upper Limb Motor Function in Subacute Stroke Patients

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms